Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: Results from the Dutch population-based PHAROS MDS registry

2015-12-01

Leukemia , Volume 29 - Issue 12 p. 2449- 2451

Additional Metadata
Persistent URL	doi.org/10.1038/leu.2015.220, hdl.handle.net/1765/81411
Journal	Leukemia
Organisation	Department of Hematology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Dinmohamed, A., van Norden, Y., Visser, O., Posthuma, H., Huijgens, P., Sonneveld, P., … Jongen-Lavrencic, M. (2015). Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: Results from the Dutch population-based PHAROS MDS registry. Leukemia, 29(12), 2449–2451. doi:10.1038/leu.2015.220

Publication